H.C. Wainwright reiterated coverage on Mirum Pharmaceuticals with a new price target

12/18/23 11:54:26 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

H.C. Wainwright reiterated coverage of Mirum Pharmaceuticals with a rating of Buy and set a new price target of $58.00 from $60.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$MIRM

Date	Price Target	Rating	Analyst
5/19/2025	$73.00	Buy	H.C. Wainwright
4/17/2024	$48.00	Buy	Stifel
12/18/2023	$60.00 → $58.00	Buy	H.C. Wainwright
11/20/2023	$37.00	Overweight	Analyst
11/13/2023	$60.00	Overweight	Morgan Stanley
10/24/2023	$50.00	Overweight	Cantor Fitzgerald
10/17/2023	$62.00	Outperform	Evercore ISI
9/20/2023	$70.00	Mkt Outperform	JMP Securities